Welcome to our dedicated page for BlackRock ESG Capital Allocation Term Trust SEC filings (Ticker: ECAT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on BlackRock ESG Capital Allocation Term Trust's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into BlackRock ESG Capital Allocation Term Trust's regulatory disclosures and financial reporting.
Saba Capital Management and its affiliates have significantly increased their stake in BlackRock ESG Capital Allocation Term Trust (ECAT). The amended Schedule 13D/A (Amendment No. 25) reports that Saba Capital, Saba Capital Management GP, LLC, and Boaz R. Weinstein collectively beneficially own 26,842,444 common shares, representing 27.02% of ECAT’s outstanding common stock, based on 99,345,793 shares outstanding as of 6/30/25.
The filing states that approximately $399,024,176 was paid to acquire the ECAT common shares, using investor subscription proceeds, capital appreciation, and ordinary-course margin borrowings. All reported shares are held with shared voting and shared dispositive power, and the positions are owned by funds and accounts advised by Saba Capital, which are entitled to dividends and sale proceeds.
BlackRock ESG Capital Allocation Term Trust (ECAT) reported an insider transaction by a 10% owner. On 11/24/2025, the reporting person executed a sale of 10,891 shares of common stock at a price of $15.65 per share, coded as an "S" transaction. After this sale, the reporting person reported 26,842,444 shares beneficially owned in an indirect capacity. The filing was made on Form 4 by a single reporting person and reflects a routine update to their equity holdings.
Saba Capital Management, L.P., a 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported a sale of common shares. On 11/19/2025, Saba disposed of 9,750 shares of ECAT common stock in an open-market sale at a price of $15.64 per share. After this transaction, Saba reported beneficial ownership of 26,853,335 ECAT shares, held indirectly. This filing is a routine disclosure of insider trading activity required for large shareholders.
BlackRock ESG Capital Allocation Term Trust (ECAT) reported an insider transaction by a 10% owner on a Form 4. On 11/17/2025, the reporting person executed a sale of 44,604 shares of common stock at a price of $15.85 per share. After this transaction, the reporting person reported 26,863,085 shares of ECAT common stock beneficially owned in an indirect capacity. The filing reflects a routine update to the insider’s reported holdings and confirms the relationship as a 10% owner of the trust.
Saba Capital Management, L.P., a reporting person associated with BlackRock ESG Capital Allocation Term Trust (ECAT), reported open-market sales of the trust’s common stock on a Form 4. On 11/13/2025, it sold 62,082 shares at $16.45 per share, and on 11/14/2025 it sold 90,456 shares at $16.30 per share. After these transactions, the reporting person indirectly beneficially owned 26,907,689 common shares of ECAT.
BlackRock ESG Capital Allocation Term Trust (ECAT): A Form 4 shows a 10% owner reported open-market sales. Saba Capital Management, L.P. executed two sales of ECAT common stock: 17,653 shares at $16.28 on 11/10/2025 and 39,740 shares at $16.39 on 11/11/2025. Following these transactions, the reporting person beneficially owns 27,060,227 shares, held indirectly.
Saba Capital Management, L.P. filed a Form 4 for BlackRock ESG Capital Allocation Term Trust (ECAT), reporting an open-market sale of 57,053 common shares at $16.10 per share on 11/06/2025.
After this transaction, the filer reported 27,117,620 shares beneficially owned on an indirect basis. The filing was made by one reporting person.
BlackRock ESG Capital Allocation Term Trust (ECAT): Saba Capital Management, L.P., a 10% owner, reported open‑market sales of ECAT common stock. On November 4, 2025, it sold 3,600 shares at $16.30, and on November 5, 2025, it sold 49,369 shares at $16.30. Following the November 5 transaction, Saba reported 27,174,673 shares beneficially owned on an indirect basis.
BlackRock ESG Capital Allocation Term Trust (ECAT): Saba Capital Management, L.P., reported a Form 4 transaction as a 10% owner. On 11/03/2025, it sold 70,661 common shares at $16.40 per share. Following the sale, Saba Capital beneficially owned 27,227,642 shares, reported as indirect ownership. The filing was made by one reporting person.
BlackRock ESG Capital Allocation Term Trust (ECAT) disclosed a Form 4 from 10% owner Saba Capital Management, L.P. reporting two open-market sales of common stock. Saba sold 78,022 shares at $16.46 on October 30, 2025, and 24,045 shares at $16.42 on October 31, 2025. Following these trades, Saba reported indirect beneficial ownership of 27,298,303 shares.